The Ministry of Health and Prevention (MoHAP) has established a strategic partnership with AstraZeneca, a leading biopharmaceutical company, to promote healthy living and combat non-communicable diseases. The primary goal of this collaboration is to improve the quality of life for individuals and communities by developing a world-class healthcare system.
During a formal signing ceremony in Dubai, Dr. Hussain Abdul Rahman Al Rand, the Assistant Undersecretary for the Public Health Sector, and Ruud Dobber, AstraZeneca Executive Vice President for the Biopharmaceuticals Business Unit, signed a Memorandum of Understanding (MoU) that outlines specific areas of cooperation and coordination. These areas include the prevention of oncology, cardiovascular diseases, renal diseases, and respiratory diseases.
Apart from supporting national initiatives aimed at promoting healthy lifestyles and reducing morbidity rates associated with non-communicable diseases, the partnership will also facilitate the planning, implementation, and strategic follow-up of relevant initiatives. The MoU also mandates the organisation of workshops, events, and initiatives that contribute to raising awareness and education on enhancing the quality of life and combating non-communicable diseases.
Moreover, the partnership will provide support for training and capacity building programmes related to the areas covered by the scope of cooperation between the two parties.
Dr. Hussein Al Rand highlighted that the collaboration between MoHAP and AstraZeneca would not only support the National Policy for Non-Communicable Diseases (NCDs) but also contribute to improving the quality of life for individuals and society by promoting healthy practices as part of the National Wellbeing Strategy 2031. He expressed optimism that this partnership would yield positive results in enhancing the health and safety of the community. One of the primary objectives of this partnership is to organise educational and awareness programmes aimed at reducing non-communicable diseases nationwide.
In addition, Sameh El Fangary, Country President for the GCC at AstraZeneca, expressed his pride in partnering with MoHAP and his anticipation of collaborating to combat non-communicable diseases and enhance the quality of healthy life. He emphasised that the constructive collaboration between the government and the private sector would positively impact people’s lives and health. Furthermore, he reiterated AstraZeneca’s commitment to supporting the UAE’s vision, achieving its goals in the field of healthy quality of life, and contributing to building a world-class healthcare system.